세계의 마이크로니들 인플루엔자 백신 시장 보고서(2025년)

The microneedle flu vaccine is an innovative vaccination method that uses a small, patch-like array of microscopic needles to painlessly deliver the influenza vaccine into the skin. This approach offers a minimally invasive, efficient, and user-friendly alternative to traditional intramuscular injections. It is designed to enhance vaccine accessibility, increase patient compliance, facilitate self-administration, and improve immunization coverage, especially in large-scale public health initiatives.

The main product types of microneedle flu vaccines include hollow microneedles, solid microneedles, coated microneedles, and dissolving microneedles. A hollow microneedle is a micro-scale needle with a central lumen, allowing for the direct injection of liquid formulations into the skin. These vaccines can be administered through various routes, such as oral, parenteral, and nasal, and are distributed through several channels, including hospital pharmacies, retail pharmacies, and online pharmacies. Applications for these vaccines include flu vaccination, seasonal flu prevention, pediatric vaccines, and vaccines for the elderly.

The microneedle flu vaccine market research report is one of a series of new reports from The Business Research Company that provides microneedle flu vaccine market statistics, including microneedle flu vaccine industry global market size, regional shares, competitors with a microneedle flu vaccine market share, detailed microneedle flu vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the microneedle flu vaccine industry. This microneedle flu vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The microneedle flu vaccine market size has grown rapidly in recent years. It will grow from $1.51 billion in 2024 to $1.67 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth during the historic period can be attributed to the increasing global burden of seasonal influenza, rising awareness about the benefits of vaccination, government efforts to improve immunization coverage, a growing preference for minimally invasive drug delivery methods, and the early clinical success of microneedle vaccines in animal models.

The microneedle flu vaccine market size is expected to see rapid growth in the next few years. It will grow to $2.48 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The anticipated growth in the forecast period is driven by the expansion of pandemic preparedness initiatives, increasing preference for needle-free vaccination methods, broader application of microneedles for diseases beyond influenza, rising demand for patient-friendly vaccination options, and enhanced manufacturing scalability of microneedle patches. Key trends during this period include a shift toward dissolvable microneedle technologies, a growing focus on self-administered vaccine models, integration of microneedles with wearable health monitoring systems, a rise in clinical trials for microneedle-based influenza vaccines, and the adoption of microneedle platforms for pediatric and elderly populations.

The increasing prevalence of needle phobia is expected to drive the growth of the microneedle flu vaccine market. Needle phobia, also known as trypanophobia, is an intense fear or anxiety triggered by the sight, sensation, or anticipation of needle-based procedures, often leading individuals to avoid necessary medical interventions. This condition is primarily fueled by psychological sensitivity and negative past experiences, creating long-term fear and avoidance behavior. Microneedle flu vaccines provide a minimally invasive and nearly painless alternative, which reduces psychological barriers to vaccination and encourages better patient compliance. For example, in February 2025, the American Society for Clinical Pathology (ASCP) reported that approximately 50% to 60% of children experience needle phobia, with the fear being most prevalent between the ages of 4 and 6. As a result, the growing prevalence of needle phobia is contributing to the expansion of the microneedle flu vaccine market.

Leading companies in the microneedle flu vaccine market are focusing on securing investments to accelerate the development of patch-based RNA vaccines. These efforts support early-stage research and collaboration, advancing next-generation vaccine delivery technologies. For example, in March 2024, the Biomedical Advanced Research and Development Authority (BARDA), a U.S.-based government agency, announced a $50 million investment through the Patch Forward Prize to fast-track the development of microneedle patch-based RNA vaccines targeting influenza and COVID-19. This initiative aims to drive innovation by funding concept development and supporting the progression of combination products into Phase I clinical trials. The program fosters collaboration between vaccine developers and patch manufacturers, with the goal of overcoming technical and regulatory challenges, improving vaccine accessibility, and bolstering national preparedness for infectious diseases.

In January 2024, Gylden Pharma Limited (formerly Emergex Vaccines Holding Limited), a UK-based clinical-stage biotechnology company, partnered with DEKA Research & Development Corp. to enhance patient-friendly drug delivery through advanced microneedle-based intradermal administration technologies. The collaboration seeks to evaluate the compatibility and effectiveness of combining Emergex's immunotherapeutic candidates with DEKA's microneedle applicator for potential clinical use. DEKA Research & Development Corp., a U.S.-based company specializing in microneedle solutions, will play a pivotal role in advancing this technology.

Major players in the microneedle flu vaccine market are Merck & Co. Inc., Sanofi SA, AstraZeneca plc, Novartis AG, Becton Dickinson and Company (BD), AptarGroup, Corium International, CosMED Pharmaceutical Co. Ltd., Vaxxas, PharmaJet, Inovio Pharmaceuticals, Vaxess Technologies, FluGen Inc., Debiotech S.A., Micron Biomedical Inc., NanoPass Technologies Limited, Micropoint Technologies Pte Ltd., TSRL Inc., Verndari Inc., and Microdermics Inc.

North America was the largest region in the microneedle flu vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in microneedle flu vaccine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the microneedle flu vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The microneedle flu vaccine market consists of sales of polymer-based microneedle patches, hydrogel-forming microneedles, silicon microneedle arrays, biodegradable microneedle systems, metallic microneedles, and lipid-based microneedle formulations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Microneedle Flu Vaccine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on microneedle flu vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for microneedle flu vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The microneedle flu vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Hollow Microneedle; Solid Microneedle; Coated Microneedle; Dissolving Microneedle
• 2) By Route Of Administration: Oral; Parenteral; Nasal
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 4) By Application: Flu Vaccination; Seasonal Flu Prevention; Pediatric Vaccines; Elderly Vaccines
• Subsegments:
• 1) By Hollow Microneedle: Single-Use Hollow Microneedles; Multiple-Use Hollow Microneedles; Polymer-Based Hollow Microneedles; Silicon-Based Hollow Microneedles
• 2) By Solid Microneedle: Metal Solid Microneedles; Silicon Solid Microneedles; Polymer Solid Microneedles; Glass Solid Microneedles
• 3) By Coated Microneedle: Drug-Coated Microneedles; Vaccine-Coated Microneedles; Biodegradable Coated Microneedles; Nano-Coated Microneedles
• 4) By Dissolving Microneedle: Fast-Dissolving Microneedles; Slow-Release Microneedles; Hydrogel-Based Dissolving Microneedles; Sugar-Based Dissolving Microneedles
• Companies Mentioned: Merck & Co. Inc.; Sanofi SA; AstraZeneca plc; Novartis AG; Becton Dickinson and Company (BD)
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Microneedle Flu Vaccine Market Characteristics

3. Microneedle Flu Vaccine Market Trends And Strategies

4. Microneedle Flu Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Microneedle Flu Vaccine Growth Analysis And Strategic Analysis Framework

• 5.1. Global Microneedle Flu Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Microneedle Flu Vaccine Market Growth Rate Analysis
• 5.4. Global Microneedle Flu Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Microneedle Flu Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Microneedle Flu Vaccine Total Addressable Market (TAM)

6. Microneedle Flu Vaccine Market Segmentation

• 6.1. Global Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hollow Microneedle
• Solid Microneedle
• Coated Microneedle
• Dissolving Microneedle
• 6.2. Global Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Nasal
• 6.3. Global Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Microneedle Flu Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Flu Vaccination
• Seasonal Flu Prevention
• Pediatric Vaccines
• Elderly Vaccines
• 6.5. Global Microneedle Flu Vaccine Market, Sub-Segmentation Of Hollow Microneedle, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Use Hollow Microneedles
• Multiple-Use Hollow Microneedles
• Polymer-Based Hollow Microneedles
• Silicon-Based Hollow Microneedles
• 6.6. Global Microneedle Flu Vaccine Market, Sub-Segmentation Of Solid Microneedle, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metal Solid Microneedles
• Silicon Solid Microneedles
• Polymer Solid Microneedles
• Glass Solid Microneedles
• 6.7. Global Microneedle Flu Vaccine Market, Sub-Segmentation Of Coated Microneedle, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug-Coated Microneedles
• Vaccine-Coated Microneedles
• Biodegradable Coated Microneedles
• Nano-Coated Microneedles
• 6.8. Global Microneedle Flu Vaccine Market, Sub-Segmentation Of Dissolving Microneedle, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fast-Dissolving Microneedles
• Slow-Release Microneedles
• Hydrogel-Based Dissolving Microneedles
• Sugar-Based Dissolving Microneedles

7. Microneedle Flu Vaccine Market Regional And Country Analysis

• 7.1. Global Microneedle Flu Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Microneedle Flu Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Microneedle Flu Vaccine Market

• 8.1. Asia-Pacific Microneedle Flu Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Microneedle Flu Vaccine Market

• 9.1. China Microneedle Flu Vaccine Market Overview
• 9.2. China Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Microneedle Flu Vaccine Market

• 10.1. India Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Microneedle Flu Vaccine Market

• 11.1. Japan Microneedle Flu Vaccine Market Overview
• 11.2. Japan Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Microneedle Flu Vaccine Market

• 12.1. Australia Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Microneedle Flu Vaccine Market

• 13.1. Indonesia Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Microneedle Flu Vaccine Market

• 14.1. South Korea Microneedle Flu Vaccine Market Overview
• 14.2. South Korea Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Microneedle Flu Vaccine Market

• 15.1. Western Europe Microneedle Flu Vaccine Market Overview
• 15.2. Western Europe Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Microneedle Flu Vaccine Market

• 16.1. UK Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Microneedle Flu Vaccine Market

• 17.1. Germany Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Microneedle Flu Vaccine Market

• 18.1. France Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Microneedle Flu Vaccine Market

• 19.1. Italy Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Microneedle Flu Vaccine Market

• 20.1. Spain Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Microneedle Flu Vaccine Market

• 21.1. Eastern Europe Microneedle Flu Vaccine Market Overview
• 21.2. Eastern Europe Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Microneedle Flu Vaccine Market

• 22.1. Russia Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Microneedle Flu Vaccine Market

• 23.1. North America Microneedle Flu Vaccine Market Overview
• 23.2. North America Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Microneedle Flu Vaccine Market

• 24.1. USA Microneedle Flu Vaccine Market Overview
• 24.2. USA Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Microneedle Flu Vaccine Market

• 25.1. Canada Microneedle Flu Vaccine Market Overview
• 25.2. Canada Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Microneedle Flu Vaccine Market

• 26.1. South America Microneedle Flu Vaccine Market Overview
• 26.2. South America Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Microneedle Flu Vaccine Market

• 27.1. Brazil Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Microneedle Flu Vaccine Market

• 28.1. Middle East Microneedle Flu Vaccine Market Overview
• 28.2. Middle East Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Microneedle Flu Vaccine Market

• 29.1. Africa Microneedle Flu Vaccine Market Overview
• 29.2. Africa Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Microneedle Flu Vaccine Market Competitive Landscape And Company Profiles

• 30.1. Microneedle Flu Vaccine Market Competitive Landscape
• 30.2. Microneedle Flu Vaccine Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton Dickinson and Company (BD) Overview, Products and Services, Strategy and Financial Analysis

31. Microneedle Flu Vaccine Market Other Major And Innovative Companies

• 31.1. AptarGroup
• 31.2. Corium International
• 31.3. CosMED Pharmaceutical Co. Ltd.
• 31.4. Vaxxas
• 31.5. PharmaJet
• 31.6. Inovio Pharmaceuticals
• 31.7. Vaxess Technologies
• 31.8. FluGen Inc.
• 31.9. Debiotech S.A.
• 31.10. Micron Biomedical Inc.
• 31.11. NanoPass Technologies Limited
• 31.12. Micropoint Technologies Pte Ltd.
• 31.13. TSRL Inc.
• 31.14. Verndari Inc.
• 31.15. Microdermics Inc.

32. Global Microneedle Flu Vaccine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Microneedle Flu Vaccine Market

34. Recent Developments In The Microneedle Flu Vaccine Market

35. Microneedle Flu Vaccine Market High Potential Countries, Segments and Strategies

• 35.1 Microneedle Flu Vaccine Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Microneedle Flu Vaccine Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Microneedle Flu Vaccine Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer